Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trialsAdem Y. Dawed, Koen F. Dekkers, Andrea Mari et al.|The Lancet Diabetes & Endocrinology|2022Cited by 114
Profiles of Glucose Metabolism in Different Prediabetes Phenotypes, Classified by Fasting Glycemia, 2-Hour OGTT, Glycated Hemoglobin, and 1-Hour OGTT: An IMI DIRECT StudyAndrea Tura, Margit Bergstrom, Eleonora Grespan et al.|Diabetes|2021Cited by 43
Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Clinical TrialsEllen M. Apperloo, Hiddo J.L. Heerspink, Katherine R. Tuttle et al.|Diabetes Care|2025Cited by 42
Influence of Postprandial Hyperglycemic Conditions on Arterial Stiffness in Patients With Type 2 DiabetesDaniel Gordin, Per‐Henrik Groop, Markku Saraheimo et al.|The Journal of Clinical Endocrinology & Metabolism|2016Cited by 38
Hypoxia-Inducible Factor 1-Alpha Release After Intracoronary Versus Intramyocardial Stem Cell Therapy in Myocardial InfarctionMariann Gyöngyösi, Gerald Maurer, Rayyan Hemetsberger et al.|Journal of Cardiovascular Translational Research|2009Cited by 18